Immunization with RCC-derived ExVs restrained the growth of RCC tumors in a mouse model as well as facilitating the induction of a stronger specific cytotoxic CD8+T cell response via the Fas ligand/Fas mediated apoptotic signaling pathway [113] in vitro. The gene discussed is CD8A; the disease is renal cell carcinoma.